FibroTest
A non-invasive test for assessing liver fibrosis
Overview[edit | edit source]
FibroTest is a non-invasive diagnostic test used to evaluate the degree of liver fibrosis in patients with chronic liver disease. It is an alternative to liver biopsy, which is the traditional method for assessing liver fibrosis but is invasive and carries certain risks.
Background[edit | edit source]
Liver fibrosis is the excessive accumulation of extracellular matrix proteins, including collagen, that occurs in most types of chronic liver diseases. It results from the liver's response to repeated injury and can lead to cirrhosis, liver failure, and hepatocellular carcinoma. Early detection and monitoring of liver fibrosis are crucial for managing chronic liver diseases effectively.
Methodology[edit | edit source]
FibroTest combines the results of several blood tests to generate a score that correlates with the degree of liver fibrosis. The test measures the levels of specific biomarkers, including:
These biomarkers are used in a proprietary algorithm to calculate the FibroTest score, which ranges from 0 to 1. The score is then interpreted to determine the stage of fibrosis, from F0 (no fibrosis) to F4 (cirrhosis).
Clinical Use[edit | edit source]
FibroTest is particularly useful in patients with hepatitis C, hepatitis B, non-alcoholic fatty liver disease (NAFLD), and alcoholic liver disease. It is used to:
- Assess the severity of liver fibrosis
- Monitor disease progression
- Evaluate the effectiveness of treatment
Advantages[edit | edit source]
FibroTest offers several advantages over liver biopsy:
- It is non-invasive, reducing the risk of complications such as bleeding and infection.
- It can be repeated easily to monitor changes in liver fibrosis over time.
- It provides a more comprehensive assessment of liver fibrosis, as liver biopsy samples only a small portion of the liver.
Limitations[edit | edit source]
While FibroTest is a valuable tool, it has limitations:
- It may be less accurate in patients with hemolysis, Gilbert's syndrome, or acute inflammation.
- It is not suitable for patients with cholestasis or acute hepatitis.
- The test's accuracy can be affected by factors such as age, body mass index, and diabetes.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
